Edwards Lifesciences Corp. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Edwards Lifesciences Corp. (EW) shares rose 1.77% to $93.66, outperforming competitors Abbott, Medtronic, and Stryker during a broader market decline. This marks the stock's fourth consecutive day of gains, though it remains 2.73% below its 52-week high. Trading volume was lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Edwards Lifesciences Corp. (EW) rallied 1.77% to $93.66 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.32% to 7,728.20 and Dow Jones Industrial Average falling 0.34% to 53,791.85.
This was the stock's fourth consecutive day of gains.
Edwards Lifesciences Corp. closed 2.73% below its 52-week high of $96.29, which the company reached on July 7th.
The stock outperformed some of its competitors Tuesday, as Abbott Laboratories (ABT) rose 1.01% to $109.72, Medtronic PLC (MDT) rose 1.42% to $90.68, and Stryker Corp. (SYK) rose 0.68% to $348.15.
Trading volume (3.1 M) remained 1.9 million below its 50-day average volume of 5.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 11, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-11-26 1651ET